CB Insights
Technology Market Intelligence
Technology Market Intelligence
Morningside Venture Partners is a New York City-based collective of investment professionals and business builders.
Phone:
60 E 8th Street
New York, 10003
New York, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2020-12-16 | Curai Health | Series B | $27.5M | General Catalyst, and Khosla Ventures |
| 2020-12-03 | EverlyWell | Series D | $175M | BlackRock, Foresite Capital, Goodwater Capital, Greenspring Associates, Highland Capital Partners, Lux Capital, and The Chernin Group |
| 2020-12-01 | Tallac Therapeutics | Series A | $62M | Lightstone Ventures, Matrix Partners China, MRL Ventures, and venBIO |
| 2019-06-10 | Alyce | Series A | $11.5M | Boston Seed Capital, General Catalyst, Golden Ventures, Manifest Investment Partners, and Victress Capital |
| 2016-01-01 | Cognito Therapeutics | Series A |
